FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition - PubMed

Affiliations

• PMID: 21071512
• DOI: 10.1158/1541-7786.MCR-10-0081

Free article

FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition

Yufa Li et al. Mol Cancer Res. 2010 Dec.

Free article

Abstract

FMNL2 is a member of diaphanous-related formins that control actin-dependent processes such as cell motility and invasion. Its overexpression in metastatic cell lines and tissues of colorectal carcinoma has been associated with aggressive tumor development in our previous study. But its specific role in cancer is largely unknown. Here we report that FMNL2 is involved in epithelial-mesenchymal transition (EMT) maintenance in human colorectal carcinoma cells. A positive correlation between FMNL2 and vimentin expression and an inverse correlation between FMNL2 and E-cadherin expression were found in colorectal carcinoma cell lines and cancer tissues. Specific knockdown of FMNL2 led to an epithelial-state transition, confirmed by the cobblestone-like phenotype, upregulation of E-cadherin, α-catenin, and γ-catenin, and downregulation of vimentin, snail, slug. Loss of FMNL2 expression lowered the ability of TGF-β to induce cell invasion and EMT, as shown by morphology and the expression levels. Upregulation of vimentin, slug, snail, downregulation of E-cadherin and activation of receptor-Smad3 phosphorylation were observed in M5 and MDCK cells induced by TGF-β, whereas altered expression of these markers was not obvious in FMNL2-depleting M5 cells. High levels of activation of p-MAPK and p-MEK, but not p-PI3K and p-AKT, were observed in SW480/FMNL2+ cells compared with control cells. Treatment with U0126 could abrogate the activation of p-MAPK and p-MEK, whereas LY294002 treatment had no effect on the PI3K/AKT pathway. In conclusion, these findings identify a novel EMT and tumor promoting function for FMNL2, which is involved in TGF-β-induced EMT and colorectal carcinoma cell invasion via Smad3 effectors, or in collaboration with MAPK/MEK pathway.

Similar articles

• FMNL2 is a positive regulator of cell motility and metastasis in colorectal carcinoma.

  Zhu XL, Zeng YF, Guan J, Li YF, Deng YJ, Bian XW, Ding YQ, Liang L. Zhu XL, et al. J Pathol. 2011 Jul;224(3):377-88. doi: 10.1002/path.2871. Epub 2011 Apr 19. J Pathol. 2011. PMID: 21506128

• CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.

  Cho SH, Park YS, Kim HJ, Kim CH, Lim SW, Huh JW, Lee JH, Kim HR. Cho SH, et al. Int J Oncol. 2012 Jul;41(1):211-8. doi: 10.3892/ijo.2012.1453. Epub 2012 Apr 30. Int J Oncol. 2012. PMID: 22552741

• Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.

  Zuo JH, Zhu W, Li MY, Li XH, Yi H, Zeng GQ, Wan XX, He QY, Li JH, Qu JQ, Chen Y, Xiao ZQ. Zuo JH, et al. J Cell Biochem. 2011 Sep;112(9):2508-17. doi: 10.1002/jcb.23175. J Cell Biochem. 2011. PMID: 21557297

• Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.

  Bagnato A, Rosanò L. Bagnato A, et al. Cells Tissues Organs. 2007;185(1-3):85-94. doi: 10.1159/000101307. Cells Tissues Organs. 2007. PMID: 17587812 Review.

• Colon cancer at the molecular level--usefulness of epithelial-mesenchymal transition analysis.

  Todosi AM, Gavrilescu MM, Aniţei GM, Filip B, Scripcariu V. Todosi AM, et al. Rev Med Chir Soc Med Nat Iasi. 2012 Oct-Dec;116(4):1106-11. Rev Med Chir Soc Med Nat Iasi. 2012. PMID: 23700897 Review.

Cited by

• Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients.

  Martins-de-Souza D, Guest PC, Harris LW, Vanattou-Saifoudine N, Webster MJ, Rahmoune H, Bahn S. Martins-de-Souza D, et al. Transl Psychiatry. 2012 Mar 13;2(3):e87. doi: 10.1038/tp.2012.13. Transl Psychiatry. 2012. PMID: 22832852 Free PMC article.

• Formin-like 1 (FMNL1) Is Associated with Glioblastoma Multiforme Mesenchymal Subtype and Independently Predicts Poor Prognosis.

  Higa N, Shinsato Y, Kamil M, Hirano T, Takajo T, Shimokawa M, Minami K, Yamamoto M, Kawahara K, Yonezawa H, Hirano H, Furukawa T, Yoshimoto K, Arita K. Higa N, et al. Int J Mol Sci. 2019 Dec 17;20(24):6355. doi: 10.3390/ijms20246355. Int J Mol Sci. 2019. PMID: 31861134 Free PMC article.

• FMNL2 regulates actin for endoplasmic reticulum and mitochondria distribution in oocyte meiosis.

  Pan MH, Zhang KH, Wu SL, Pan ZN, Sun MH, Li XH, Ju JQ, Luo SM, Ou XH, Sun SC. Pan MH, et al. Elife. 2024 May 15;12:RP92732. doi: 10.7554/eLife.92732. Elife. 2024. PMID: 38747713 Free PMC article.

• MicroRNA-206 functions as a tumor suppressor in colorectal cancer by targeting FMNL2.

  Ren XL, He GY, Li XM, Men H, Yi LZ, Lu GF, Xin SN, Wu PX, Li YL, Liao WT, Ding YQ, Liang L. Ren XL, et al. J Cancer Res Clin Oncol. 2016 Mar;142(3):581-92. doi: 10.1007/s00432-015-2053-8. Epub 2015 Oct 29. J Cancer Res Clin Oncol. 2016. PMID: 26515696

• cAMP and Epac in the regulation of tissue fibrosis.

  Insel PA, Murray F, Yokoyama U, Romano S, Yun H, Brown L, Snead A, Lu D, Aroonsakool N. Insel PA, et al. Br J Pharmacol. 2012 May;166(2):447-56. doi: 10.1111/j.1476-5381.2012.01847.x. Br J Pharmacol. 2012. PMID: 22233238 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program